These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29084869)

  • 21. Onconeural antibodies in patients with neurological symptoms: detection and clinical significance.
    Raspotnig M; Vedeler CA; Storstein A
    Acta Neurol Scand Suppl; 2011; (191):83-8. PubMed ID: 21711262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.
    Honnorat J
    Acta Neurol Scand Suppl; 2006; 183():64-8. PubMed ID: 16637934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antineuronal autoantibodies in paraneoplastic neurological diseases].
    Blaes F; Tschernatsch M
    Dtsch Med Wochenschr; 2008 Feb; 133(6):252-5. PubMed ID: 18236352
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurological paraneoplastic syndromes in lung cancer patients.
    Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
    Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A brainstem paraneoplastic syndrome associated with prostate cancer.
    Berger JR; Bensalem M; Dalmau J
    J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):934-5. PubMed ID: 19608787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraneoplastic neurological syndromes--diagnosis and management.
    Blaes F
    Curr Pharm Des; 2012; 18(29):4518-25. PubMed ID: 22612756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Index of suspicion.
    Kincaid CR; Nield LS; Hsieh D; Friederich R; Pelszynski MM; Mulè F; Roberts K
    Pediatr Rev; 2006 Aug; 27(8):307-13. PubMed ID: 16882760
    [No Abstract]   [Full Text] [Related]  

  • 28. [Paraneoplastic neurological syndromes in 2008].
    Honnorat J
    Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraneoplastic syndromes involving the nervous system.
    Darnell RB; Posner JB
    N Engl J Med; 2003 Oct; 349(16):1543-54. PubMed ID: 14561798
    [No Abstract]   [Full Text] [Related]  

  • 30. Onconeural versus paraneoplastic antigens?
    Eichmüller SB; Bazhin AV
    Curr Med Chem; 2007; 14(23):2489-94. PubMed ID: 17979702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes.
    Voltz R
    J Neurol; 2006 Sep; 253 Suppl 5():V33-8. PubMed ID: 16998752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 3: Neurological paraneoplastic syndromes, involving the central nervous system.
    Bentea G; Sculier C; Grigoriu B; Meert AP; Durieux V; Berghmans T; Sculier JP
    Lung Cancer; 2017 Apr; 106():83-92. PubMed ID: 28285700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An immunoprecipitation assay for the detection of onconeural antibodies.
    Monstad SE; Vedeler CA
    Acta Neurol Scand Suppl; 2006; 183():71-2. PubMed ID: 16637936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunotherapy for paraneoplastic neurological syndromes].
    Nomura K
    Nihon Naika Gakkai Zasshi; 2008 Aug; 97(8):1830-7. PubMed ID: 18833703
    [No Abstract]   [Full Text] [Related]  

  • 35. Paraneoplastic Demyelinating Sensorimotor Neuropathy Delaying the Diagnosis of an Underlying Acute Lymphoblastic Leukemia in a Child.
    Chandar R; Seetharam S; Gopakumar KG; Appanraj P; Cs G; Rajeswari B; Nair M; Thankamony P
    J Oncol Pract; 2018 Oct; 14(10):629-631. PubMed ID: 30133345
    [No Abstract]   [Full Text] [Related]  

  • 36. Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment.
    Bataller L; Dalmau J
    Semin Neurol; 2003 Jun; 23(2):215-24. PubMed ID: 12894387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mass spectrometric detection of antigen-specific immunoglobulin peptides in paraneoplastic patient sera.
    Maat P; VanDuijn M; Brouwer E; Dekker L; Zeneyedpour L; Luider T; Smitt PS
    J Autoimmun; 2012 Jun; 38(4):354-60. PubMed ID: 22459491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostics of paraneoplastic neurological syndromes.
    Zoccarato M; Gastaldi M; Zuliani L; Biagioli T; Brogi M; Bernardi G; Corsini E; Bazzigaluppi E; Fazio R; Giannotta C; Nobile-Orazio E; Costa G; Iorio R; Evoli A; Mariotto S; Ferrari S; Galloni E; De Riva V; Zardini E; Franciotta D; Giometto B
    Neurol Sci; 2017 Oct; 38(Suppl 2):237-242. PubMed ID: 29030766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review.
    Sæther SG; Schou M; Kondziella D
    BMC Psychiatry; 2017 May; 17(1):161. PubMed ID: 28468645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.